Thorne HealthTech priced its IPO of 7 million shares at $10 each.
The underwriters have an option to purchase up to an additional 1.050 million shares.
The shares begin trading today on the Nasdaq under THRN and the offering is expected to close Sept. 27.
Thorne HealthTech utilizes testing and data to create improved product efficacy and deliver personalized solutions to consumers, health professionals, and corporations. Read more.
